Biotech startup Valar Labs focuses on AI tool Vesta, which predicts responsiveness to cancer treatments like BCG therapy, aiming to optimize treatment choices for patients.
Valar Labs founders seek to eliminate trial and error in cancer treatments by providing informed decisions through AI support, potentially preventing ineffective treatments and saving time for patients.
[
add
]
[
|
|
...
]